Benlysta

The Big Winner of the EU Drug Approval Bonanza
Motley Fool
Sat, 05/21/11 - 11:05 am
Benlysta
Human Genome Sciences
Vibativ
Theravance
GSK
Victrelis
Merck
Xgeva
Amgen
Yervoy
Bristol-Myers Squibb
Fampyra
Acorda Therapeutics
Biogen Idec
Human Genome Sciences Will Be Profitable, Eventually
Motley Fool
Thu, 04/14/11 - 10:33 pm
Human Genome Sciences
GSK
Benlysta
Bayer
ONYX Pharmaceuticals
Elan
Biogen Idec
Human Genome Pumps Up Its Pipeline
Seeking Alpha
Sat, 03/19/11 - 09:58 am
Human Genome Sciences
FP-1039
Benlysta
Human Genome: Buy the Pipeline Before Glaxo Does
Seeking Alpha
Wed, 03/16/11 - 10:43 am
GSK
Human Genome Sciences
lupus
Benlysta
HGSI Flies High on Benlysta Nod
Yahoo/Zacks
Sat, 03/12/11 - 01:18 pm
Human Genome Sciences
Benlysta
lupus
The New Lupus Drug: What The Wags Are Saying
Pharmalot
Thu, 03/10/11 - 10:21 am
lupus
Human Genome Sciences
Benlysta
FDA approves Human Genome's lupus drug
Bizjournals.com
Thu, 03/10/11 - 07:49 am
Benlysta
FDA
Human Genome Sciences
lupus
Trading Human Genome Sciences' Pending FDA Decision
Seeking Alpha
Tue, 03/8/11 - 06:26 pm
FDA
Human Genome Sciences
Benlysta
Is This the Week for Human Genome's Benlysta?
Seeking Alpha
Mon, 03/7/11 - 10:47 am
lupus
Benlysta
Human Genome Sciences
Loss at HGSI Wider than Expected
Yahoo/Zacks
Sat, 02/26/11 - 10:05 am
Human Genome Sciences
Benlysta
lupus
Human Genome: Betting on Benlysta Approval
Seeking Alpha
Tue, 02/22/11 - 09:40 am
Benlysta
FDA
Human Genome Sciences
lupus
5 Breakthrough Drugs for 2011
Barron's
Thu, 02/3/11 - 10:06 am
Benlysta
Human Genome Sciences
GSK
ipilimumab
Bristol-Myers Squibb
Vertex Pharmaceuticals
JNJ
Telaprevir
Novartis
Incyte
INCB-18424
Xarelto
Bayer
Value Investing, Biotech Style
Motley Fool
Sat, 01/29/11 - 11:35 am
investors
Benlysta
Human Genome Sciences
GSK
Cell Therapeutics
obesity. Orexigen Therapeutics
Vertex Pharmaceuticals
Exelixis
Human Genome Sciences Tries to Put Toothpaste Back In the Tube
WSJ Online
Fri, 01/14/11 - 12:17 pm
Human Genome Sciences
GSK
Benlysta
lupus
Human Genome sets Lupus drug sales goal
Marketwatch
Tue, 01/11/11 - 12:27 pm
lupus
Human Genome Sciences
Benlysta
Three Upcoming Make-or-Break Biotech Approvals
Seeking Alpha
Sun, 12/19/10 - 11:22 am
Vertex Pharmaceuticals
Telaprevir
Merck
hepatitis C
cystic fibrosis
Human Genome Sciences
Benlysta
lupus
MannKind
Afrezza
inhaled insulin
Director Of Equity Research At RBC Capital Markets Covers Phase III Data For Multiple New Drugs; Find Out The Stocks That Investors Should Look At
Yahoo/Wall Street Transcript
Sat, 12/18/10 - 12:24 pm
Athenahealth
Abbott Laboratories
Beckman Coulter
Agilent
AstraZeneca
Provenge
Dendreon
Benlysta
Human Genome Sciences
Telaprevir
Vertex Pharmaceuticals
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Human Genome Sciences and GlaxoSmithKline Announce FDA Extension of BENLYSTA® PDUFA Target Date to March 10, 2011
Yahoo/BusinessWire
Sat, 12/4/10 - 11:58 am
Human Genome Sciences
GSK
Benlysta
PDUFA
Human Genome downgraded over lupus drug potential
Marketwatch
Wed, 11/17/10 - 12:59 pm
lupus
Benlysta
Human Genome Sciences

Pages